Trade Spotlight | What should you do with Laurus Labs, Glenmark Pharma, Ashoka Buildcon, and Vakrangee? Dayanand Saini | December 28, 2021 | Stocks News | No Comments Here#39;s what Karan Pai of GEPL Capital, recommends investors should do with these stocks when the market resumes trading today Related Posts Deploy risk-averse modified Call butterfly strategy on Nifty: Shubham Agarwal No Comments | Jan 11, 2021 Standard Capita Standalone December 2020 Net Sales at Rs 0.09 crore, down 11.55% Y-o-Y No Comments | Feb 24, 2021 ICICI Lombard share price hits 52-week high after in-principle nod to acquire Bharti AXA General Insurance No Comments | Dec 2, 2020 Technical View | Nifty forms #39;Spinning Top#39;, more selling pressure likely below 17,250 No Comments | Feb 17, 2022 About The Author Dayanand Saini